1,4-dihydropyridine has been researched along with Alloxan Diabetes in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gómez-Pliego, R; Gómez-Zamudio, J; Ibarra-Barajas, M; Velasco-Bejarano, B; Villalobos-Molina, R | 1 |
Baumane, L; Boucher, JL; Isajevs, S; Leonova, E; Rostoka, E; Sjakste, N; Sjakste, T; Sokolovska, J | 1 |
Bergeron, R; Chapman, KT; Ellsworth, KP; Geissler, WM; Harris, G; Myers, RW; Ogawa, AK; Willoughby, CA; Yao, J | 1 |
Hanna, ST; Tang, G; Wang, R; Wu, L; Wu, Y | 1 |
4 other study(ies) available for 1,4-dihydropyridine and Alloxan Diabetes
Article | Year |
---|---|
Effect of bis-1,4-dihydropyridine in the kidney of diabetic rats.
Topics: Albuminuria; Animals; Body Weight; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dihydropyridines; In Vitro Techniques; Kidney; Male; Organ Size; Perfusion; Proteinuria; Rats; Rats, Wistar; Streptozocin; Vasodilation | 2013 |
New 1,4-Dihydropyridines Down-regulate Nitric Oxide in Animals with Streptozotocin-induced Diabetes Mellitus and Protect Deoxyribonucleic Acid against Peroxynitrite Action.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dihydropyridines; DNA; Down-Regulation; Kidney; Liver; Male; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peroxynitrous Acid; Protective Agents; Rats; Rats, Wistar; Reactive Nitrogen Species; Reactive Oxygen Species; Xanthine Dehydrogenase | 2016 |
Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dihydropyridines; Disease Models, Animal; Enzyme Inhibitors; Glycogen Phosphorylase; Hypoglycemic Agents; Mice | 2003 |
Altered L-type Ca(2+) channel currents in vascular smooth muscle cells from experimental diabetic rats.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arteries; Bucladesine; Calcium Channels, L-Type; Cells, Cultured; Cyclic AMP; Diabetes Mellitus, Experimental; Dihydropyridines; Electric Conductivity; Glucose; Male; Muscle, Smooth, Vascular; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Tail | 2000 |